Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Annals of Clinical and Laboratory Science|March 5, 2008
Mutation of Glu78 of the AVP-NPII gene impairs neurophysin as a carrier protein for arginine vasopressin in a family with neurohypophyseal diabetes insipidusYong-Wha Lee, Kyung Wook Lee, Ji Won Ryu, et al.
Korean Diabetes Journal|June 10, 2010
Regulation of glucose control in people with type 2 diabetes: a review and consensusJeong-Taek Woo, Kyung Soo Park, Dong-Won Byun, et al.
Calcified Tissue International|October 10, 2009
Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic womenYoon-Sok Chung, Sung-Kil Lim, Ho-Yeon Chung, et al.
BMJ Open|February 22, 2026
Comparative risk of the neurodegenerative outcomes between sodium-glucose co-transporter 2 (SGLT2) inhibitors and thiazolidinediones in type 2 diabetes: a multicentre cohort study using the Korean healthcare database (2014-2025)Sang Joon Park, Hye Jeong Kim, Mihae Seo, et al.
Yonsei Medical Journal|April 11, 2014
Efficacy and safety of weekly alendronate plus vitamin D₃ 5600 IU versus weekly alendronate alone in Korean osteoporotic women: 16-week randomized trialKwang Joon Kim, Yong-Ki Min, Jung-Min Koh, et al.
Endocrinology and Metabolism (Seoul, Korea)|December 11, 2014
Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with OsteoporosisIn Jin Cho, Ho Yeon Chung, Sung Woon Kim, et al.
Clinical Therapeutics|December 11, 2017
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, et al.
Journal of Bone and Mineral Metabolism|September 22, 2018
Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in KoreaDong Won Byun, Seong-Hwan Moon, Tak Kim, et al.
Pageof 6